← Evidence map

ReviewReumatologia2026

The role and potential of CD19-targeted chimeric antigen receptor T-cell therapy in systemic sclerosis.

Krzysztof Michalak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42761848